- Home
- DBVT vs TCMD Comparison
DBVT vs TCMD Comparison
Compare DBVT & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- TCMD
- Stock Information
- Founded
- DBVT 2002
- TCMD 1995
- Country
- DBVT France
- TCMD United States
- Employees
- DBVT N/A
- TCMD N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- TCMD Medical/Dental Instruments
- Sector
- DBVT Health Care
- TCMD Health Care
- Exchange
- DBVT Nasdaq
- TCMD Nasdaq
- Market Cap
- DBVT 273.6M
- TCMD 288.7M
- IPO Year
- DBVT N/A
- TCMD 2016
- Fundamental
- Price
- DBVT $9.66
- TCMD $13.31
- Analyst Decision
- DBVT Buy
- TCMD Hold
- Analyst Count
- DBVT 4
- TCMD 3
- Target Price
- DBVT $14.81
- TCMD $13.50
- AVG Volume (30 Days)
- DBVT 35.5K
- TCMD 251.4K
- Earning Date
- DBVT 07-29-2025
- TCMD 08-04-2025
- Dividend Yield
- DBVT N/A
- TCMD N/A
- EPS Growth
- DBVT N/A
- TCMD N/A
- EPS
- DBVT N/A
- TCMD 0.63
- Revenue
- DBVT $3,800,000.00
- TCMD $298,851,000.00
- Revenue This Year
- DBVT $1,743.46
- TCMD $8.85
- Revenue Next Year
- DBVT $1,045.66
- TCMD $8.24
- P/E Ratio
- DBVT N/A
- TCMD $21.31
- Revenue Growth
- DBVT N/A
- TCMD 6.15
- 52 Week Low
- DBVT $2.21
- TCMD $8.61
- 52 Week High
- DBVT $12.78
- TCMD $21.10
- Technical
- Relative Strength Index (RSI)
- DBVT 49.63
- TCMD 67.31
- Support Level
- DBVT $8.91
- TCMD $12.94
- Resistance Level
- DBVT $10.34
- TCMD $13.23
- Average True Range (ATR)
- DBVT 0.54
- TCMD 0.36
- MACD
- DBVT -0.03
- TCMD 0.00
- Stochastic Oscillator
- DBVT 52.61
- TCMD 96.75
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.